Strategic change within the pharmaceutical industry: The impact of direct-to-consumer advertising for prescription medicines

被引：1
作者：
Hughes-Morgan M. [1 ]
Kendrick J.L. [2 ]
Morgan F.W. [3 ]
Stoltman J.J. [3 ]
机构：
[1] Eli Broad College, Business Michigan State University, East Lansing
[2] Eli Lilly and Company, Lexington
[3] School of Business Administration, Wayne State University, Detroit
来源：
International Journal of Information Systems and Change Management | 2010年 / 4卷 / 03期
关键词：
Direct-to-consumer; Direct-to-consumer advertising; DTC; DTCA; FDA; Food and drug administration; Pharmaceutical industry;
D O I：
10.1504/IJISCM.2010.033078
中图分类号：
学科分类号：
摘要：
Advertising prescription medicines directly to consumers is a controversial practice. At present, only two economically developed countries, the USA and New Zealand, allow complete direct to consumer advertising. The positive side is that consumers have access to greater levels of information about new and leading products. The negative side is the imbalance in presentation of benefits and risks via advertising. In this paper, we review the pros and cons of this practice and discuss its impact on product development and performance. © 2010 Inderscience Enterprises Ltd.
引用
收藏
页码：246 / 257
页数：11
相关论文
共 67 条
[1]  
Abel G.A., Burstein H.J., Hevelone N.D., Weeks J.C., Cancer-related direct-to-consumer advertising: Awareness, perceptions, and reported impact among patients undergoing active cancer treatment, Journal of Clinical Oncology, September, 27, pp. 4182-4176, (2009)
[2]  
Ameer B., Krivoy N., Direct-to-consumer/patient advertising of genetic testing: A position statement of the American college of clinical pharmacology, Journal of Clinical Pharmacology, 49, pp. 886-888, (2009)
[3]  
FDA revisits DTC advertising, American Society of Health-System Pharmacists, (2005)
[4]  
ASHP to FDA: DTC ads should point viewers to MedWatch, American Society of Health-System Pharmacists, (2008)
[5]  
An S., Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: Application of the availability heuristic, Health Communication, 23, pp. 499-505, (2008)
[6]  
Arnold M., Changing channels, Medical Marketing and Media, 40, pp. 34-42, (2005)
[7]  
Axelrod A., Moore D., Direct-to-consumer advertising: A classic case of cognitive dissonance, DTC Perspectives, (2004)
[8]  
Becker L.B., Huh J., Direct-to-consumer prescription drug advertising: Understanding its consequences, International Journal of Advertising, 24, 4, pp. 441-466, (2005)
[9]  
Blocki R., Just what the patient ordered: 6 ingredients of successful DTP, Medical Marketing and Media, 41, pp. 52-53, (2006)
[10]  
Bolling J., Direct mail, done right, Pharmaceutical Executive, 25, pp. 92-93, (2005)
1234567